The amount of Tranq available on Philadelphia's streets has increased.

According to a new report, overdose deaths involving heroin, fentanyl, and an animal tranquilizer not authorized for human use are on the rise in Philadelphia. The U.S. Food and Drug Administration has primarily licensed the tranquilizer, known as xylazine, as a veterinary medication. It is a non-opioid sedative and painkiller. Its official street name in Philadelphia is "tranq." Xylazine, is also referred to as tranq dope, or zombie drug. It is not currently a prohibited substance under federal law and has not been given a human use permit by the US Food and Drug Administration.

Disturbing footage of substance abusers posted on social media has revealed the extent of the "tranq" pandemic that are affecting the streets of Philadelphia, Pennsylvania, US. Videos that have gone viral appear to show a Philadelphia neighborhood populated with zombie-like addicts who are seen dozing off on the streets. Nurses working in mobile medical units are now available in that city to assist anyone experiencing severe Xylazine side effects.

According to a report from 2022, Maryland had the second-highest percentage of "tranq dope"-related overdose deaths in the US, after Philadelphia, with about 20% of these deaths. 90% of Philadelphia's drug supply now contains xylazine, which has also been found in drug stash homes in New York City.

According to a physician, the most common cause of death in America for people between the ages of 18 and 42 has become this skin-rotting narcotic that, when used in large doses, turns consumers into "zombies." As a result, there has been an increase in the drug overdose issue in the US, with users losing limbs to severe skin infections.

Large animals like horses are tranquilized using xylazine, which is not meant for human consumption. It has been added by drug dealers towards heroin, cocaine, and other illegal substances to boost their potency and profit margins.

Since xylazine has a longer half-life than fentanyl and is more difficult to eliminate from the body with overdose-reversing medications like naloxone, it is especially concerning because it can cause fatality even in tiny doses. Since veterinarians require xylazine, it is not prohibited, but some states want to regulate it.

Although xylazine was reportedly initially discovered in Germany in 1962, it is unclear when "tranq" first surfaced in Philadelphia's illicit drug market. Its popularity in Philadelphia is due to its alleged capacity to extend and intensify the effects of a fentanyl high. This is important since fentanyl has essentially replaced heroin as the preferred illegal drug in the city.

Xylazine reduces pain and lowers brain activity in humans. Since Tranq lowers blood pressure and the central nervous system, using it with opioids increases danger. The user's breathing and pulse rate slows down as a outcome. Xylazine can be found in illegal narcotics, prescription medications, and street drugs, frequently without a user's knowledge.

Compared to the high from heroin and other opioids, the "high" from fentanyl lasts for a short period of time. In order to prolong the effects of fentanyl and replicate the high of heroin, xylazine may be used. But not every fentanyl addict is looking for xylazine intentionally. Sometimes consumers don't realize xylazine is a component of the drugs they buy and take.

The drug makes an individual drowsy. However, the raw, dry wounds that erupt from the injection site are its most unpleasant symptom. If neglected, the skin sores decompensate quickly and can be so bad that amputation of the diseased bodily part may be necessary.

Xylazine has rapidly migrated to at least 36 states across the US. Associated overdose deaths were reported in Texas, Massachusetts, Maryland, Ohio, and Maryland. New York City, Los Angeles, and San Francisco have also issued public health alerts concerning the drug.

The DEA issued a public safety advisory in March regarding the "widespread threat" of fentanyl combined with xylazine, stating that in 2022, roughly 23% of the fentanyl powder and 7% of the fentanyl tablets it recovered had contained xylazine.

The governor of Pennsylvania announced that his administration would add xylazine to the state's list of prohibited substances, solidifying restrictions on the drug and enabling law enforcement to file charges against those who violate them.

To Schedule your drug test with Precision Mobile Testing, Call Today! #precisionmobiletesting